Clinical Trial Update: Ketamine for Opioid Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from the University of Maryland, Baltimore is evaluating ketamine for opioid use disorder and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Opioid Use Disorder | Phase 2 | Status: RECRUITING